ft 17 apr 93 intern compani news genentech quadrupl net incom genentech california base biotechnolog compani taken 1990 roch hold switzerland yesterday report impress jump 1993 first quarter net incom dollar 14 3m four time level year ago profit translat earn per share 12 cent three cent year ago struck revenu dollar 153m dollar 129m quarter 1992 higher product sale royalti incom contract revenu contribut 19 per cent increas turnov mr kirk raab presid chief execut said result good even import compani file approv market pulmozym new cystic fibrosi drug us europ canada pulmozym claim reduc rate respiratori infect improv lung function patient mr raab note recent five year ago drug mere scientif idea line genentech heavi invest research develop first quarter r amp expens dollar 74 2m dollar 66m first quarter 1992 r amp spend repres 48 per cent total revenu quarter sale protropin human growth hormon increas 8 per cent dollar 52 2m sale activas pa heart attack drug 11 per cent higher dollar 49 2m genentech also said begun phase ii trial genet engin treatment drug patient infect hiv viru wall street biotechnolog stock suffer along drug stock amid concern clinton administr plan healthcar reform genentech share price declin dollar 1 2 yesterday dollar 33 5 8 close